Emerging evidence for a central epinephrine-innervated α1- adrenergic system that regulates behavioral activation and is impaired in depression

Neuropsychopharmacology

Volumn 28, Issue 8, 2003, Pages 1387-1399

  Stone, Eric A ^a,b   Lin, Yan ^a   Rosengarten, Helen ^a   Kramer, H Kenneth ^a   Quartermain, David ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

1 adrenoceptors; Depression; Epinephrine; Inactivity; Motor activity

Indexed keywords

ADRENALIN; ALPHA 1 ADRENERGIC RECEPTOR; ANTIDEPRESSANT AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; MITOGEN ACTIVATED PROTEIN KINASE; NEUROTRANSMITTER; POSTSYNAPTIC RECEPTOR;

ADRENERGIC SYSTEM; AUTONOMIC NERVOUS SYSTEM; BASAL GANGLION; BEHAVIOR; BRAIN; CENTRAL NERVOUS SYSTEM; CHEMICAL ANALYSIS; CLINICAL RESEARCH; DEPRESSION; DESENSITIZATION; DISEASE PREDISPOSITION; DOPAMINERGIC NERVE CELL; DOPAMINERGIC TRANSMISSION; HUMAN; INNERVATION; MONOAMINE NERVE CELL; MONOAMINERGIC SYSTEM; NEUROTRANSMISSION; NONHUMAN; NORADRENERGIC NERVE; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW; SENSITIZATION; SEROTONINERGIC NERVE CELL; TROPHIC LEVEL; ANIMAL; NERVE TRACT; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; BEHAVIOR; DEPRESSION; EPINEPHRINE; HUMANS; NEURAL PATHWAYS; RECEPTORS, ADRENERGIC, ALPHA-1;

EID: 0041383902     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.npp.1300222     Document Type: Review

References (183)

1. 1B-adrenergic receptor in female rat brain regions involved in stress and neuroendocrine function. Neurochem Int 35: 383-391.
2. Anden NE, Strombom U, Svensson TH (1973). Dopamine and noradrenaline receptor stimulation: reversal of reserpine-induced suppression of motor activity. Psychopharmacologia 29: 289-298.
3. Anisman H, Hayley S, Turrin N, Merali Z (2002). Cytokines as a stressor: implications for depressive illness. Int J Neuropsychopharmacol 5: 357-373.
4. 2-adrenergic receptors in the cerebral cortex of controls and suicide victims. Brain Res 630: 271-282.
5. Arnsten AFT, Mathew R, Ubriani R, Taylor JR, Bao-Ming L (1999). α-1 Noradrenergic receptor stimulation impairs prefrontal cortical cognitive function. Biol Psychiatry 45: 26-31.
6. Asnis GM, Sanderson WC, van Praag HM (1992). Cortisol response to intramuscular desipramine in patients with major depression and normal control subjects: a replication study. Psychiatry Res 44: 237-250.
7. Aston-Jones G, Astier B, Ennis M (1992). Inhibition of noradrenergic locus coeruleus neurons by C1 adrenergic cells in the rostral ventral medulla. Neuroscience 48: 371-381.
8. Aston-Jones G, Rajkowski J, Kubiak P, Alexinsky T (1994). Locus coeruleus neurons in monkey are selectively activated by attended cues in a vigilance task. J Neurosci 14: 4467-4480.
9. 1-adrenoceptor occupancy and number in rat lumbar spinal cord. Brain Res 260: 81-90.
10. 1-adrenoceptor binding sites. Brain Res 276: 183-187.
11. Auclair A, Cotecchia S, Glowinski J, Tassin JP (2002). D-amphetamine fails to increase extracellular dopamine levels in mice lacking alpha 1b-adrenergic receptors: relationship between functional and nonfunctional dopamine release. J Neurosci 22: 9150-9154.
12. Bakshi VP, Geyer MA (1999). Alpha-1-adrenergic receptors mediate sensorimotor gating deficits produced by intracerebral dizocilpine administration in rats. Neuroscience 92: 113-121.
13. Baraban JM, Aghajanian G (1980). Suppression of firing activity of 5-HT neurons in the dorsal raphe by alpha-adrenoceptor antagonists. Neuropharmacology 19: 355-363.
14. Berger P, King RA, Lemoine C, Mefford I (1984). Cerebrospinal fluid epinephrine concentrations: discrimination of subtypes of depression and schizophrenia. Psychopharmacol Bull 20: 412-415.
15. 1- adrenoceptor-mediated excitation of substantia nigra pars reticulata neurons. Neuroscience 98: 599-604.
16. Bing G, Filer D, Miller JC, Stone EA (1991). Noradrenergic activation of immediate early genes in rat cerebral cortex. Mol Brain Res 11: 43-46.
17. 1-adrenergic receptors prevents locomotor hyperactivity induced by subcortical D-amphetamine injection. Eur J Neurosci 6: 293-298.
18. Braga MFM, Hough CJ, Manion S, Li H (2002). Chronic stress causes impairment of 1-adrenoceptor-mediated modulation of GABAergic synaptic transmission in the basolateral amygdala. Abstr Soc Neurosci 28, Prog #103.10.
19. Brown AS, Gershon S (1993). Dopamine and depression. J Neural Transm 91: 75-109.
20. Cabib S, Giardino L, Calza L, Zanni M, Mele A, Puglisi-Allegra S (1998). Stress promotes major changes in dopamine receptor densities within the mesoaccumbens and nigrostriatal systems. Neuroscience 84: 193-200.
21. Cabib S, Puglisi-Allegra S (1996). Stress, depression and the mesolimbic dopamine system. Psychopharmacology 128: 331-342.
22. Cano J, Garcia-Uria J, Machado A, Reinoso-Suarez F (1980). Effect of cerebellar lesions on monoamine levels in various brain areas of the cat. J Neurochem 35: 1446-1448.
23. 1b-adrenergic receptor. Proc Natl Acad Sci USA 94: 11589-11594.
24. Chamba G, Weissmann D, Rousset C, Renaud B, Pujol JF (1991). Distribution of alpha-1 and alpha-2 binding sites in the rat locus coeruleus. Brain Res Bull 26: 185-193.
25. Chan-Palay V (1977). Cerebellar Dentate Nucleus: Organization, Cytology and Transmitters. Springer: Berlin. pp 297-363.
26. Checkley S, Crammer J (1977). Hormone responses to methylamphetamine in depression. Br J Psychiatry 131: 582-586.
27. Chopde C, Hote M, Mandhane S, Muthal A (1995). Glucocorticoids attenuate haloperidol-induced catalepsy through adrenal catecholamines. J Neural Transm 102: 47-54.
28. Christensen NJ, Vestergaard P, Sorensen T, Rafaelsen OJ (1980). Cerebrospinal fluid adrenaline and noradrenaline in depressed patients. Acta Psychiatr Scand 61: 178-182.
29. 1-adrenoceptor activation of the nitric oxide-cGMP pathway: relevance for hormonal facilitation of lordosis behavior. J Neurosci 19: 7191-7197.
30. Cools A (1991). Differential role of mineralocorticoid and glucocorticoid receptors in the genesis of desamphetamine-induced sensitization of mesolibmic, α1 adrenergic receptors in the ventral striatum. Neuroscience 43: 419-428.
31. D'Sa C, Duman R (2002). Antidepressants and neuroplasticity. Bipolar Disord 4: 183-194.
32. 1d-adrenergic receptor mRNA in the rat brain and spinal cord. J Chem Neuroanat 13: 115-139.
33. De Paermentier F, Mauger JM, Lowther S, Crompton MR, Katona CL, Horton RW (1997). Brain alpha-adrenoceptors in depressed suicides. Brain Res 757: 60-68.
34. Donaldson IM, Dolphin A, Jenner P, Marsden CD, Pycock C (1976). Contraversive circling behaviour produced by unilateral electrolytic lesions of the ventral noradrenergic bundle mimicking the changes seen with unilateral electrolytic lesions of the locus coeruleus. J Pharm Pharmacol 28: 329-331.
35. Drevets WC (2000). Neuroimaging studies of mood disorders. Biol Psychiatry 48: 813-829.
36. Drouin C, Darracq L, Trovero F, Blanc G, Glowinski J, Cotecchia S et al (2002). α1b-Adrenergic receptors control locomotor and rewarding effects of psychostimulants and opiates. J Neurosci 22: 2873-2884.
37. Dubocovich ML, Mogilnicka E, Areso PM (1990). Antidepressant-like activity of the melatonin receptor antagonist, luzindole(N-0774), in the mouse behavioral despair test. Eur J Pharmacol 182: 313-325.
38. Duman RS, Malberg J, Nakagawa S, D'Sa C (2000). Neuronal plasticity and survival in mood disorders. Biol Psychiatry 48: 732-739.
39. Duman RS, Malberg J, Thome J (1999). Neural plasticity to stress and antidepressant treatment. Biol Psychiatry 46: 1181-1191.
40. Duman RS, Strada SJ, Enna SJ (1985). Effect of imipramine and adrenocorticotropin administration on the rat brain norepinephrine-coupled cyclic nucleotide generating system: alterations in alpha and beta adrenergic component. J Pharmacol Exp Ther 234: 409-414.
41. 1-adrenergic stimulation in relation to the behaviour stimulating effect of modafinil; studies with experimental animals. Eur J Pharmacol 180: 49-58.
42. Engberg G, Elam M, Svensson T (1981). Effect of adrenaline synthesis inhibition on brain noradrenaline neurons in locus coeruleus. Brain Res 223: 49-58.
43. 2)-adrenoreceptor agonists in combination with the dopamine D2 agonist quinpirole produce locomotor stimulation in dopamine-depleted mice. Pharmacol Toxicol 67: 123-131.
44. Espejo EF, Miñano J (2001). Adrenergic hyperactivity and metanephrine excess in the nucleus accumbens after prefrontocortical dopamine depletion. J Neurophysiol 85: 1270-1274.
45. Ferraro L, Antonelli T, O'Connor WT, Tanganelli S, Rambert FA, Fuxe K (1997). Modafinil: an antinarcoleptic drug with a different neurochemical profile to D-amphetamine and dopamine uptake blockers. Biol Psychiatry 42: 1181-1183.
46. Ferry B, Roozendaal B, McGaugh JL (1999). Role of norepinephrine in mediating stress hormone regulation of long-term memory storage: a critical involvement of the amygdala. Biol Psychiatry 46: 1140-1152.
47. 1-adrenoreceptor activities in cultured hypothalamic slices leading to opposite noradrenaline effect on corticotropin-releasing hormone release. J Neurochem 70: 1199-1209.
48. Fujimaki K, Morinobu S, Duman R (2000). Administration of a cAMP phosphodiesterase 4 inhibitor enhances antidepressant-induction of BDNF mRNA in rat hippocampus. Neuropsychopharmacology 22: 42-51.
49. Fuller R (1982). Pharmacology of brain epinephrine neurons. Ann Rev Pharmacol Toxicol 22: 31-55.
50. Gannon MN, McEwen BS (1990). Calmodulin involvement in stress- and corticosterone-induced down-regulation of cyclic AMP-generating systems in brain. J Neurochem 55: 276-284.
51. 1-Adrenoceptors: subtypes, signaling, and roles in health and disease. Arch Med Res 30: 449-458.
52. Geyer MA, Segal DS, Mandell AJ (1972). Effect of intraventricular infusion of dopamine and norepinephrine on motor activity. Physiol Behav 8: 653-658.
53. 2 receptors interactions in the prefrontal cortex: implications for the modality of action of different types of neuroleptics. Synapse 30: 362-370.
54. Gjerris A, Jensen EW, Christensen NJ, Rafaelsen OJ (1981). Adrenaline and noradrenaline in psychiatric disorders. In: Perris C, Struwe G, Jansson B (eds) Biological Psychiatry. Elsevier: Copenhagen. pp 565-568.
55. Grenhoff J, Nisell M, Ferre S, Aston-Jones G, Svensson TH (1993). Noradrenergic modulation of midbrain dopamine cell firing elicited by stimulation of the locus coeruleus in the rat. J Neural Transm 93: 11-25.
56. 1-Adrenergic effects on dopamine neurons recorded intracellularly in the rat midbrain slice. Eur J Neurosci 7: 1707-1713.
57. Gross-Isseroff R, Dillon KA, Fieldust SJ, Biegon A (1990). Autoradiographic analysis of α1-noradrenergic receptors in the human brain postmortem. Arch Gen Psychiatry 47: 1049-1053.
58. Hahn B, Zacharko R, Anisman H (1986). Alterations of amphetamine elicited perseveration and locomotor excitation following acute and repeated stressor application. Pharmacol Biochem Behav 25: 29-33.
59. Harro J, Oreland L (2001). Depression as a spreading adjustment disorder of monoaminergic neurons: a case for primary implication of the locus coeruleus. Brain Res Rev 38: 79-128.
60. Hasegawa K (1975). Changes in the self-stimulation behavior by intraventricular injection of epinephrine, norepinephrine, isoproterenol and dopamine. Jpn J Pharmacol 25: 616-619.
61. 1-adrenoceptor function. Effects of acute and repeated administration of antidepressant drugs and electroconvulsive shock. Neuropharmacology 23: 1241-1251.
62. Herman JP, Stinus L, LeMoal M (1984). Repeated stress increases locomotor response to amphetamine. Psychopharmacology 84: 431-435.
63. 1-adrenoceptor antagonists on agonist and tilt-induced changes in blood pressure: relationships to uroselectivity. Eur J Pharmacol 373: 51-62.
64. Hokfelt T, Johansson O, Goldstein M (1984). Central catecholamine neurons as revealed by immunohistochemistry with special reference to adrenaline neurons. In: Bjorklund A, Hokfelt T (eds) Handbook of Chemical Neuroanatomy. Elsevier: New York. pp 157-276.
65. Holmes P, Masini C, Primeaux S, Garrett J, Zellner A, Stogner K et al (2002). Intravenous self-administration of amphetamine is increased in a rat model of depression. Synapse 46: 4-10.
66. 2 adrenergic receptor suggests different sleep-wake state activities and roles. Neuroscience 114: 517-521.
67. Ikeda U, Tsuruya Y, Yaginuma T (1991). α1-Adrenergic stimulation is coupled to cardiac myocyte hypertrophy. Am J Physiol 260: H953-H956.
68. 1-potentiation of β-adrenoceptor-stimulated cyclic AMP formation after repeated saline injections in Fischer 344 strain rats. Life Sci 59: 33-42.
69. Izumi J, Washizuka M, Hayashi-Kuwabara Y, Yoshinaga K, Tanaka Y, Ikeda Y et al (1997a). Protective effect of citalopram against the attenuation of the alpha-1-potentiation of cAMP formation in Fischer 344 strain rats. Behav Brain Res 83: 209-212.
70. Izumi J, Washizuka M, Kuwabara YH, Yoshinaga K, Tanaka Y, Ikeda Y et al (1997b). Evidence for a depressive-like state induced by repeated saline injections in Fisher 344 rats. Pharmacol Biochem Behav 57: 883-888.
71. 1- adrenoceptors which increase cyclic AMP accumulation in rat cerebral cortex. Eur J Pharmacol 129: 293-305.
72. 125I]-heat. J Comp Neurol 231: 190-208.
73. Katz R, Carroll B (1978). Inhibition of phenylethanolamine-N- methyltransferase and brain-stimulated reward. Psychopharmacology 57: 39-42.
74. Katz R, Carroll B, Leibler L (1978). Enhancement of drug-induced motor activity by an inhibitor of phenylethanol-N-methyltransferase. Neurosci Lett 8: 83-88.
75. Katz R, Gelbart J, Carroll B (1980). Potentiation of 1-dopa induced motor activity by an inhibitor of phenylethanolamine-N-methyltransferase. Prog Neuropsychopharmacol 4: 101-105.
76. Kelsey J (1976). Behavioral effects of intraseptal injections of adrenergic drugs in rats. Physiol Psychol 4: 433-438.
77. Kleinrok Z, Zebrowska-Lupina I (1971). Central action of phentolamine administered intraventricularly in the rat. Psychopharmacology 20: 348-354.
78. 1b- adrenoceptor. Eur Neuropsychopharmacol 10: 423-427.
79. Konsman JP, Parnet P, Dantzer R (2002). Cytokine-induced sickness behaviour: mechanisms and implications. Trends Neurosci 25: 154-159.
80. Kostowski W, Jerlicz M, Bidzinski A, Hauptmann M (1978). Evidence for the existence of two opposite noradrenergic brain systems controlling behavior. Psychopharmacology 59: 311-312.
81. Laakman G, Wittmann M, Schoen M, Zugan K, Weiss A, Meissner R et al (1986). Effects of receptor blockers (methysergide, propranolol, phentolamine, yohimbine and prazosin) on desipramine-induced pituitary hormone stimulation in humans. Psychoneuroendocrinology 11: 475-489.
82. Lin Y, Stone EA (2001). Effect of local blockade of alpha 1-adrenoceptors in various brain regions on locomotor activity and movement in mice. Abstr Soc Neurosci 27, Prog #292.4.
83. Lin Y, Stone EA, Ahsan R, Quartermain D (2002). Antagonist mapping of the mouse brain for alpha-1-adrenoceptors that regulate motor activity. Abstr Soc Neurosci 28, Prog #879.8.
84. 3H]prazosin. Acta Universit Tamper 21: 131-141.
85. Lipinski JF, Cohen BM, Zubenko GS, Waternaux C (1987). Adrenoceptors and the pharmacology of affective illness: a unifying theory. Life Sci 40: 1947-1963.
86. Lynch M, Littelton J, McKernan R, Durcan M, McMillan T, Campbell I (1983). Adrenoceptor number and function in rat cortex after ethanol and immobilization stress. Brain Res 288: 145-149.
87. 1-adrenoceptors: their role in the modulation of attention and memory formation. Pharmacol Ther 83: 49-65.
88. Maier SF (2001). Exposure to the stressor environment prevents the temporal dissipation of behavioral depression/learned helplessness. Biol Psychiatry 49: 763-773.
89. Maj J, Klimek V, Nowak G (1985). Antidepressant drugs given repeatedly increase binding to alpha 1-adrenoceptors in the rat cortex. Eur J Pharmacol 119: 113-116.
90. 2A systems. J Neural Transm 107: 1345-1359.
91. 1-adrenergic up-regulation. J Neural Transm 105: 329-342.
92. Man in't Veld AJ, Moleman P, Boomsma F, Schalekamp MADH (1987). Congenital dopamine-beta-hydroxylase deficiency. A novel orthostatic syndrome. Lancet 1: 183-187.
93. Mason ST, Roberts DC, Fibiger HC (1978). Noradrenergic influences on catalepsy. Psychopharmacology 60: 53-57.
94. Mathé JM, Nomikos GG, Hildebrand BE, Hertel P, Svensson TH (1996). Prazosin inhibits MK-801-induced hyperlocomotion and dopamine release in the nucleus accumbens. Eur J Pharmacol 309: 1-11.
95. McEwen BS (2000). Effects of adverse experiences for brain structure and function. Biol Psychiatry 48: 721-731.
96. McNaughton N, Mason ST (1980). The neuropsychology and neuropharmacology of the dorsal ascending noradrenergic bundle - a review. Prog Neurobiol 14: 157-219.
97. Mefford I (1988). Epinephrine in mammalian brain. Prog Neuropsychopharmacol 12: 365-388.
98. Mefford IN (1987). Are there epinephrine neurons in rat brain? Brain Res Rev 12: 383-395.
99. Menkes DB, Aghajanian G, McCall R (1980). Chronic antidepressant treatment enhances α-adrenergic and serotonergic responses in the facial nucleus. Life Sci 27: 45-55.
100. 1-adrenoceptors. Eur J Pharmacol 87: 35-41.
101. Menkes DB, Baraban JM, Aghajanian G (1981). Prazosin selectively antagonizes neuronal responses mediated by alpha-1 adrenoceptors in brain. Naunyn-Schmiedebergs Arch Pharmacol 317: 273-275.
102. 1-adrenoceptors following chronic antidepressant treatment. Life Sci 33: 181-188.
103. 1-adrenoceptors in the rat hypothalamus and midbrain. Eur J Pharmacol 379: 111-114.
104. 1-adrenoceptor agonist after repeated treatment with antidepressant drugs is not conditioned by B-down-regulation. Neuropharmacology 26: 1457-1461.
105. Morin D, Sapena R, Zini R, Onteniente B, Tillement JP (1996). Characterization of β-adrenergic receptors of freshly isolated astrocytes and neurons from rat brain. Life Sci 60: 315-324.
106. Morinobu S, Kuwayama N, Kawanami T, Okuyama N, Takahashi M, Totsuka S et al (1992). Influence of the acute stress on agonist-stimulated phosphinositide hydrolysis in the rat cerebral cortex. Prog Neuropsychopharmacol Biol Psychiatry 16: 561-570.
107. Murrough J, Boss-Williams K, Emery M, Bonsall R, Weiss J (2000). Depletion of brain norepinephrine does not reduce spontaneous ambulatory activity of rats in the home cage. Brain Res 883: 125-130.
108. 1-adrenoceptor-mediated collateral excitation in the regulation of the electrical activity of locus coeruleus neurons. Neuroscience 27: 921-929.
109. Nemeroff C (2002). Recent advances in the neurobiology of depression. Psychopharmacol Bull 36: 6-23.
110. Nestler EJ, Barrot M, DiLeone RJ, Eisch AJ, Gold SJ, Monteggia LM (2002). Neurobiology of depression. Neuron 34: 13-25.
111. Niittykoski M, Lappalainen R, Jolkkonen J, Haapalinna A, Riekkinen Sr P, Sirvio J (1998). Systemic administration of atipamezole, a selective antagonist of alpha-2 adrenoceptors, facilitates behavioural activity but does not influence short-term or long-term memory in trimethyltin-intoxicated and control rats. Neurosci Biobehav Rev 22: 735-750.
112. Nishino S, Fruhstorfer B, Arrigoni J, Guilleminault C, Dement WC, Mignot E (1993). Further characterization of the alpha-1 receptor subtype involved in the control of cataplexy in canine narcolepsy. J Pharmacol Exp Ther 264: 1079-1084.
113. Nowak JZ, Przybysz M, Zurawska E (1988). The melatonin generating system in the rat retina and pineal gland: effect of single and repeated electroconvulsive shock (ECS). Pol J Pharmacol Pharm 40: 573-584.
114. Ohliger-Frerking P, Horowitz J, Horwitz B (2002). Enhanced adrenergic excitation of serotonergic dorsal raphe neurons in genetically obese rats. Neurosci Lett 332: 107-110.
115. Ohta K, Ohta M, Mizuta I, Fujinami A, Shimazu S, Sato N et al (2002). The novel catecholaminergic and serotoninergic activity enhancer R-(-)-1-(benzofuran-2-yl)-2-propylaminopentane upregulates neurotrophic factor synthesis in mouse astrocytes. Neurosci Lett 328: 205-208.
116. Ossowska G, Nowak G, Kata R, Klenk-Majewska B, Danilczuk Z, Zebrowska-Lupina F (2001). Brain monoamine receptors in a chronic unpredictable stress model in rats. J Neural Transm 108: 311-319.
117. 1-Adrenoceptors in the mammalian brain: similar pharmacology but different distributions in rodents and primates. Brain Res 419: 65-75.
118. Phillipu A, Dietl H, Sinha JN (1979). In vivo release of endogenous catecholamines in the hypothalamus. Naunyn Schmiedebergs Arch Pharmacol 308: 137-143.
119. 1d-adrenoceptors in rabbit. Eur J Pharmacol 396: 9-17.
120. Plaznik A, Danysz W, Kostowski W (1984). Behavioral evidence for alpha-1 adrenoceptor up- and alpha-2-adrenoceptor down regulation in the rat hippocampus after chronic desipramine treatment. Eur J Pharmacol 101: 305-306.
121. Reader T, Briere R (1983). Long-term unilateral noradrenergic denervation: monoamine content and [3H]-prazosin binding sites in rat neocortex. Brain Res Bull 11: 687-692.
122. Reinhard Jr JF, Galloway MP, Roth R (1983). Noradrenergic modulation of serotonin synthesis and metabolism. II. Stimulation by 3-isobutyl-1- methylxanthine. J Pharmacol Exp Ther 226: 764-769.
123. Roth K, Mefford I, Barchas J (1982). Epinephrine, norepinephrine, dopamine and serotonin: differential effects of acute and chronic stress on regional brain amines. Brain Res 239: 417-424.
124. Rouqier I, Claustre Y, Benavidas J (1994). Alpha-1 adrenoceptor antagonists differentially control serotonin release in the hippocampus and striatum: a microdialysis study. Eur J Pharmacol 261: 59-64.
125. Routledge C, Marsden C (1987a). Adrenaline in the CNS: in vivo evidence for a functional pathway innervating the hypothalamus. Neuropharmacology 26: 823-830.
126. Routledge C, Marsden CA (1987b). Comparison of the effects of selected drugs on the release of hypothalamic adrenaline and noradrenaline measured in vivo comparison of the effects of selected drugs on the release of hypothalamic adrenaline and noradrenaline measured in vivo. Brain Res 426: 103-111.
127. Sakaue M, Hoffman BB (1991). Glucocorticoids induce transcription and expression of the alpha-1B adrenergic receptor gene in DTT1 MF-2 smooth muscle cells. J Clin Invest 88: 385-389.
128. 1D adrenoceptors in modulating locomotor responses. Abstr Soc Neurosci 28, Prog #879.6.
129. Sauter A, Ueta K, Goldstein M (1980). Effect of DBH- and PNMT-inhibition on brain adrenaline and noradrenaline in animals exposed to stress. In: Fuxe K, Goldstein M, Hokfelt B, Hokfelt T (eds) Central Adrenaline Neurons. Pergamon Press: Oxford. pp 97-103.
130. Scammell TE, Estabrooke IV, McCarthy MT, Chemelli RM, Yanagisawa M, Miller MS et al (2000). Hypothalamic arousal regions are activated during modafinil-induced wakefulness. J Neurosci 20: 8620-8628.
131. 1-adrenergic receptor subtypes in lower urinary tract symptoms. Br J Urol Int 86: 11-22.
132. Segal D, Geyer M, Weiner B (1975). Strain differences during intraventricular infusion of norepinephrine: possible role of receptor sensitivity. Science 189: 301-303.
133. Segal DS, McAllister C, Geyer MA (1974). Ventricular infusion of norepinephrine and amphetamine: direct versus indirect action. Pharmacol Biochem Behav 2: 79-86.
134. Simon P, Hemet C, Ramassamy C, Costentin J (1995). Non-amphetaminic mechanism of stimulant locomotor effect of modafinil in mice. Eur Neuropsychopharmacol 5: 509-514.
135. Singh A, Einstein R, Lavidis N (2001). Effects of restraint stress on responsiveness of atria and vas deferens in Sprague-Dawley rats. J Autonom Pharmacol 21: 255-261.
136. Snider RS, Maiti A, Snider SR (1976). Cerebellar pathways to ventral midbrain and nigra. Exp Neurol 53: 714-728.
137. Snider SR, Snider RS (1979). Kainic acid: enduring alterations in cerebellar morphology and in cerebral catecholamine and GABA concentrations after cerebellar injection in the rat. Neurosci Lett 12: 339-342.
138. Spreng M, Cotecchia S, Schenk F (2001). A behavioral study of alpha-1b adrenergic receptor knockout mice: increased reaction to novelty and selectively reduced learning capacities. Neurobiol Learn Mem 75: 214-229.
139. 1 excitatory modulation of pontine reticular formation neurons. J Neurosci 14: 6481-6487.
140. 1-adrenoceptor binding sites in rat brain. Eur J Pharmacol 139: 259-266.
141. Stone EA (1979). Reduction by stress of norepinephrine-stimulated accumulation of cyclic AMP in rat cerebral cortex. J Neurochem 32: 1335-1337.
142. Stone EA (1983). Problems with current catecholamine hypotheses of antidepressant drugs. Speculations leading to a new hypothesis. Behav Brain Sci 6: 535-578.
143. 1B-adrenoceptors in modafinil-induced behavioral activity. Synapse 46: 269-270.
144. 1-adrenoceptors in motor activity in mice. Synapse.
145. Stone EA, Kramer HK (2001a). Biphasic action of corticosterone on alpha 1B-adrenoceptors in DDT1 MF2 cells. FASEB J 15: A549.
146. Stone EA, Lin Y, Itteera A, Quartermain D (2001b). Pharmacological evidence for the role of brain alpha 1B-adrenoceptor activity in the motor activity and spontaneous movement in mice. Neuropharmacology 40: 254-261.
147. Stone E, Lin Y, Suckow R, Quartermain D (2002b). Stress-induced subsensitivity to modafinil and its prevention by corticosteroids. Pharmacol Biochem Behav 73: 971-978.
148. Stone EA, Zhang Y (1995). Adrenoceptor antagonists block c-fos response to stress in the mouse brain. Brain Res 694: 279-286.
149. Stone EA, Manavalan JS, Basham DA, Bing G (1994). Effect of yohimbine on nerve growth factor mRNA and protein levels in rat hippocampus. Neurosci Lett 167: 11-13.
150. Stone EA, Quartermain D (1999). Alpha 1-adrenergic neurotransmission, corticosterone and behavioral depression. Biol Psychiatry 46: 1287-1300.
151. Stone EA, Rosegarten H, Kramer HK (2001d). Modafinil has partial agonist activity at alpha 1B-adrenoceptors in vitro and in vivo. Abstr Soc Neurosci, 27, Prog #292.4.
152. 3H]prazosin binding is correlated with behavioral immobility. Eur J Pharmacol 420: 97-102.
153. 1-adrenergic neurotransmission is necessary for behavioral activation to environmental change in mice. Neuroscience 94: 1245-1252.
154. Suba EA, McKenna TM, Williams TJ (1992). In vivo and in vitro effects of endotoxin on vascular responsiveness to norepinephrine and signal transduction in the rat. Circ Shock 36: 127-133.
155. Taylor JA, Twomey TM, Schach von Wittenau M (1977). The metabolic fate of prazosin. Xenobiotica 7: 357-364.
156. Thomas SA, Palmiter RD (1997). Disruption of the dopamine beta-hydroxylase gene in mice suggests roles for norepinephrine in motor function, learning and memory. Behav Neurosci 111: 579-589.
157. Torda T, Kvetnansky R, Petrikova M (1985). Effect of repeated immobilization stress on central and peripheral adrenoceptors in rats. Endo Exp 19: 157-163.
158. Tremblay LK, Naranjo CA, Cardenas L, Herrmann N, Busto UE (2002). Probing brain reward system function in major depressive disorder - altered response to dextroamphetamine. Arch Gen Psychiatry 59: 409-416.
159. Trovero F, Blanc G, Herve D, Vezina P, Glowinski J, Tassin J-P (1992). Contribution of an alpha1-adrenergic receptor subtype to the expression of the 'ventral tegmental area syndrome'. Neuroscience 47: 69-76.
160. U'Prichard D, Loftus D, Stolk J (1988). Functional association between epinephrine-containing neurons and α-adrenoceptors in discrete brain areas: analysis in inbred rat strains. In: Stolk J, U'Prichard D, Fuxe K (eds) Epinephrine in the Central Nervous System. Oxford: New York. pp 195-211.
161. van Dijken HH, Mos J, Van Der Heyden JAM, Tilders FJH (1992). Characterization of stress-induced long-term behavioural changes in rats: evidence in favor of anxiety. Physiol Behav 52: 945-951.
162. Vantini G, Perry B, Guchhait R, U'Prichard D, Stolk J (1984). Brain epinephrine systems: detailed comparison of adrenergic and noradrenergic metabolism, receptor number and in vitro regulation, in two inbred rat strains. Brain Res 296: 49-65.
163. 3H]prazosin binding sites in the rat. Brain Res 310: 360-362.
164. 1B receptors are the main postsynaptic mediators of adrenergic excitation in brainstem motoneurons, a single-cell RT-PCR study. J Chem Neuroanat 22: 157-166.
165. Wakabayashi I, Hatake K, Kakishita E, Hishida S, Nagai K (1989). Desensitization of alpha-1 adrenergic receptor mediated smooth muscle contraction in aorta from endotoxic rats. Life Sci 45: 509-515.
166. Watson S, Gallagher P, Del-Estal D, Hearn A, Ferrier IN, Young AH (2002). Hypothalamic-pituitary-adrenal axis function in patients with chronic depression. Psychol Med 32: 1021-1028.
167. Weiss J, Bonsall RW, Demetrikopoulos MK, Emery MS, West CHK (1998). Galanin: a significant role in depression? Ann NY Acad Sci 863: 364-382.
168. Weiss J, Demetrikopoulos M, West C, Bonsall R (1996). Hypothesis linking the noradrenergic and dopaminergic systems in depression. Depression 3: 225-245.
169. 1B adrenoceptors in rat paraventricular nucleus overlap with, but do not mediate, the induction of c-fos expression by osmotic or restraint stress. Neuroscience 76: 901-913.
170. Williams J, Marshall K (1987). Membrane properties and adrenergic responses in locus coeruleus neurons of young rats. J Neurosci 7: 3687-3694.
171. Williams NG, Zhong H, Minneman KP (1998). Differential coupling of α1-, α2-, and β-adrenergic receptors to mitogen-activated protein kinase pathways and differentiation in transfected PC12 cells. J Biol Chem 273: 24624-24632.
172. Woolverton WL (1987). Evaluation of the role of norepinephrine in the reinforcing effects of psychomotor stimulants in rhesus monkeys. Pharmacol Biochem Behav 26: 835-939.
173. Wurtman RJ (2002). Stress and the adrenocortical control of epinephrine synthesis. Metab Clin Exp 51: 11-14.
174. 1B-adrenoceptor antagonist, on periarterial nerve electrical stimulation-induced double-peaked constrictor responses in isolated dog splenic arteries. Jpn J Pharmacol 89: 429-432.
175. Yang X-M, Gorman AL, Dunn AJ (1990). The involvement of central noradrenergic systems and corticotropin-releasing factor in defensive-withdrawal in rats. J Pharmacol Exp Ther 255: 1064-1070.
176. 1-adrenoceptor subtypes. I. Radioligand binding studies. J Pharmacol Exp Ther 286: 841-847.
177. 1D-adrenoceptor protein detectable in rat tissues? Naunyn Schmiedebergs Arch Pharmacol 355: 438-446.
178. Yntema OP, Korf J (1987). Transient suppression by stress of haloperidol induced catalepsy by the activation of the adrenal medulla. Psychopharmacology 91: 131-134.
179. Zebrowska-Lupina I, Przegalinski E, Sloniec M, Kleinrok Z (1977). Clonidine-induced locomotor hyperactivity in rats: the role of central postsynaptic α-adrenoceptors. Naunyn Schmiedeberg's Arch Pharmacol 297: 227-231.
180. Zebrowska-Lupina I, Stelmasiak M, Porowska A, Pietrasiewicz T (1988). Immobilization stress modifies locomotor response to catecholamine receptor agonists in rats. Pol J Pharmacol Pharm 40: 441-450.
181. Zhang Y, Itteera A, Quartermain D, Stone EA (2002). Effects of stress, corticosterone and LPS on alpha 1-adrenergically induced motor hyperactivity. Abstr Soc Neurosci 26, Prog #45.4.
182. Zilles K, Qu M, Schleicher A (1993). Regional distribution and heterogeneity of alpha-adrenoceptors in the rat and human central nervous system. J Hirnforschung 34: 123-132.
183. 1B-adrenergic receptor causes apoptotic neurodegeneration: multiple system atrophy. Nat Med 6: 1388-1394.